The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Blog
Tuesday 16 June 2015
Last year, I was invited to join the Cancer Drugs Fund (CDF) Panel, nominated by Cancer52, an alliance that represents the interests of rare and less common cancer groups. As one of three lay representatives on the panel, my role is to make sure that the patient voice is heard in decision-making...
News
Tuesday 2 June 2015
Today’s media covered the National Institute of Health and Care Excellence (NICE)’s decision not to recommend olaparib (Lynparza) for use on the NHS in England, with NICE commenting that the evidence provided showed that the price was too high for the benefit it could provide for women with ovarian...
News
Monday 1 June 2015
In May 650 MPs were elected across the UK to represent you in parliament. It's hugely important to us to make sure they're listening to your concerns and needs. With this in mind, we're launching our brand new campaign in the House of Commons on 23 June. With your help we want to ensure as many MPs...
Blog
Tuesday 26 May 2015
As a scientist I have suffered the disappointment of seeing potential drugs I have worked on failing to make it into use. However, my frustrations as a scientist are nothing compared to the disappointment felt by women with ovarian cancer when drugs such as olaparib fail to get approved. Olaparib...

Pages